Form 8-K - Current report:
SEC Accession No. 0001193125-23-133476
Filing Date
2023-05-03
Accepted
2023-05-03 09:02:01
Documents
12
Period of Report
2023-05-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d286559d8k.htm   iXBRL 8-K 22233
  Complete submission text file 0001193125-23-133476.txt   139359

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA biib-20230503.xsd EX-101.SCH 2858
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE biib-20230503_lab.xml EX-101.LAB 17234
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE biib-20230503_pre.xml EX-101.PRE 10817
6 EXTRACTED XBRL INSTANCE DOCUMENT d286559d8k_htm.xml XML 3204
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 23881914
SIC: 2836 Biological Products, (No Diagnostic Substances)